CARDIAC MONITORDESIGNED TO OUTPERFORM,
BUILT TO OUTLAST
DESIGNED TO OUTPERFORM
Having pioneered the introduction of the world’s first Bluetooth®-enabled insertable cardiac monitor (ICM), Abbott is leading innovation once more with the introduction of Assert-IQ™ ICM.
With Assert-IQ™ ICM, you will be able to detect arrhythmias more accurately,1-3 see electrogram (EGM) details more clearly*, and gain additional insights to enable more informed decision making,4 all powered by state-of-the-art Bluetooth® technology and remote programming capabilities.**
We have created an ICM that provides meaningful value in the areas that are most important to you and your clinic.
ASSERT-IQ™ ICM
THE LATEST CARDIAC
MONITORING INNOVATION
ADVANCED ALGORITHMS PROVIDE CLINICALLY ACTIONABLE DATA
AI ALGORITHMS CLASSIFY ATRIAL FIBRILLATION (AF) AND PAUSE EPISODES THROUGH SUPERVISED LEARNING
DEVELOPMENT
SYSTEM REMOVES FALSE EPISODES BASED ON AI CLASSIFICATION
WORKFLOW
AF DETECTION DISCRIMINATOR
| 5 | Assert-IQ™ ICM devices utilize a 5-step AF detection discriminator that focuses on R-R interval patterns and P-waves in EGMs to verify if an event is true or false before AI is applied in the cloud. |
INDUSTRY-LEADING ARRHYTHMIA DETECTION
5-STEP SEQUENCIAL AF DETECTION DISCRIMINATOR
AV, atrioventricular.
AI PERFORMANCE
SIGNIFICANT FALSE POSITIVE REDUCTION WHILE MAINTAINING HIGH SENSITIVITY
KEY EPISODES* – OPTIMIZED FOR EACH ARRHYTHMIA TYPE
Key Episode technology provides data management flexibility while maintaining time-to-diagnosis for patients.3,7
Key Episode technology sets Assert-IQ™ ICM apart from others by allowing clinicians the ability to see all episodes or 3 key episodes, depending on the needs of the patient or clinic.3
| ASSERT-IQ™ ICM | MEDTRONIC REVEAL LINQ‡ | MEDTRONIC REVEAL LINQ II‡ | |
|---|---|---|---|
| Arrhythmia type | Key Episode Selection: Up to 3 EGMs per day, per arrhythmia type4 | Selection: One EGM per day based on wireless data priority8 | Selection: Three auto episode EGMs per day, per arrhythmia type9 |
| Atrial fibrillation |
| One EGM per day send wirelessly Patient manual transmission optional to see all information8 | Same standard criteria set for all arrhythmia types
|
| Tachycardia |
| ||
| Bradycardia |
| ||
| Pause |
|
Assert-IQ™ ICM is Magnetic Resonance (MR) Conditional for both 1.5 Tesla (T) and 3T full-body scans.
There is no wait limit after insertion, which allows timely patient care.*
EXCLUSIVE IQ INSIGHTS
With IQ insights, clinicians can make data-driven decisions faster and more confidently. Additional sensors capture these exclusive diagnostics:
Leading PREMATURE VENTRICULAR CONTRACTIONS (PVCs) detection algorithm that offers the ability to capture consecutive events including couplets and triplets.11
The only ICM that tracks ELEVATED HEART RATE WITH AND WITHOUT ACTIVITY.4, 8, 9, 12–16
BODY POSITION & POSTURE CHANGES at episode onset enables you to assess other patient factors to help adjudicate episodes.
DIRECT TREND VIEWER allows you to assess atrial fibrillation (AF), PVCs, and activity trends. Available on Merlin.net™ Patient Care Network (PCN) for the lifetime of the device.
CLEAR, CRISP EGMs
Get clear, crisp electrograms (EGMs) for improved visualization of P-waves, which could lead to a faster care decision for your patients.17
REMOTE PROGAMMING TO ENHANCE YOUR CLINIC’S WORKFLOW
Remote programming allows clinicians to adjust the settings of the Assert-IQ™ ICM, optimize device performance, and limit unnecessary alerts or transmissions for connected devices – all without requiring the patient to visit the clinic.*
Quick and easy
Data capture, encryption, and transfer to Merlin.net™ Patient Care Network (PCN) through myMerlin™ Mobile App.
LEARN MORE ABOUT REMOTE PROGRAMMING BY WATCHING THIS VIDEO
HOW THE ASSERT-IQ™ ICM IS PROGRAMMED
Assert-IQ™ ICM, sometimes referred to as a loop recorder, is powered by state-of-the-art Bluetooth® technology and remote capabilities, so you can provide reliable support for your patients and maintain an easy workflow for your clinic.
LEARN MORE FROM MERLIN.NET™ PCN:
HOW TO ENHANCE YOUR WORKFLOW FLEXIBILITY
The Merlin.net™ PCN offers a simple, intuitive, and secure remote programming solution for Assert-IQ™ ICM. With the exception of essential patient information such as name, date of birth, and reason for monitoring, all parameters can be easily and securely programmed remotely to enhance patient monitoring.
Abbott’s advanced technology in remote care ensures the process is seamless and efficient, providing healthcare professionals with the tools they need to deliver exceptional patient care.
FAST AND SECURE DATA TRANSFERS
Advanced Bluetooth® Low Energy (BLE) technology checks in every 20 seconds with the connected device (this is also known as the advertising rate), to capture, encrypt, and transfer data to the Merlin.net™ PCN quickly and easily.
WATCH THE ASSERT-IQ™ ICM
INSERTION PROCEDURE
TV
TV
Remote Programming Overview
What’s New in ICM: Beyond Diagnosis
AV Block Programming Webinar
ICM Indications Update
- Gopinathannair R, Lakkireddy D, Manyam H, et al. Improving the Specificity of Atrial Fibrillation and Tachycardia Detection in an Insertable Cardiac Monitor. Presented at: Heart Rhythm Society; Apr 20-May 1, 2022; San Francisco, USA.
- Afzal MR, Gopinathannair R, Manyam H, et al. Development and Evaluation of a New Algorithm Enhancement to Improve Specificity of Pause Detection in an Insertable Cardiac Monitor. Presented at: Heart Rhythm Society; Apr 20-May 1, 2022; San Francisco, USA.
- Gardner RS, Quartieri F, Betts TR, et al. Reducing the electrogram review burden imposed by insertable cardiac monitors. J Cardiovasc Electrophysiol. 2022;33(4):741-750. doi: 10.1111/jce.15397.
- Abbott. Assert-IQ™ ICM User Manual.
- Abbott. Merlin.net™ Artificial Intelligence for Use with Assert-IQ™ ICM User Manual.
- Data on File. Abbott - Report 91132211.
- Shehata MM, Manyam H, Gopinathannair R, et al. Evaluating the Impact of New Arrhythmia Detection Algorithms in an Insertable Cardiac Monitor. Presented at: Asia Pacific Heart Rhythm Society; November 18-20, 2022; Singapore.
- Medtronic. REVEAL LINQ‡ LNQ11 Insertable Cardiac Monitor and Patient Assistant PA96000 Clinician Manual. Accessed June 11, 2026. manuals.medtronic.com manuals/main/en_US/home/index
- Medtronic. LINQ II‡ LNQ22 Insertable Cardiac Monitor Clinician Manual. Accessed June 11, 2026. manuals.medtronic.com/manuals/main/en_US/home/index
- Data on File. Abbott - Report 90984075.
- Manyam H, Afzal MR, Gopinathannair R, et al. Evaluation of A Novel Premature Ventricular Contraction Detection Algorithm in an Insertable Cardiac Monitor. Presented at Heart Rhythm Society; Apr 20-May 1, 2022; San Francisco, USA.
- Boston Scientific. User’s Manual, LUX-Dx‡ Insertable Cardiac Monitor System M301, 2925, 2935. Accessed June 11, 2026. www.bostonscientific.com/content/dam/ bostonscientific/Rhythm Management/portfolio-group/lux-dx/ICM-User-Manual-US.pdf
- Boston Scientific. User’s Manual, LUX-Dx II‡ , LUX-Dx II+‡ Insertable Cardiac Monitor System M302, M312, 2925, 2929, 2935, 2939. Accessed June 11, 2026. www.bostonscientific.com/content/dam/elabeling/crm/52024101-001_LUX-Dx_ICM_UM_US_EN_S.pdf
- Biotronik. Technical Manual BioMonitor III‡. Accessed June 11, 2026. manuals.biotronik.com/emanuals-professionals/ BioMonitor3/BioMonitor3_US
- Biotronik. Technical Manual BioMonitor IIIm‡. Accessed June 11, 2026. manuals.biotronik.com/emanuals-professionals/ BioMonitor3m/BioMonitor3m_US
- Biotronik. Technical Manual BioMonitor IV‡. Accessed June 11, 2026. manuals.biotronik.com/emanuals-professionals/ BioMonitor4/BioMonitor4_US
- Shehata MM, Nair DG, Qu F, et al. Insertable Cardiac Monitor P-wave Visibility in a New Clinical Report. Presented at: Asia Pacific Heart Rhythm Society; November 18-20, 2022; Singapore.
™ indicates a trademark of the Abbott group of companies.
‡ Indicates a third-party trademark, which is property of its respective owner.
Bluetooth and Bluetooth logo are registered trademarks of Bluetooth SIG, Inc.